These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17380844)

  • 1. Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes.
    Grassi G; Quarti-Trevano F; Scopelliti F; Seravalle G; Cuspidi C; Mancia G
    Blood Press; 2006; 15(5):268-74. PubMed ID: 17380844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
    Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Rossini C; Muiesan ML; Paini A; Duse S; La Boria E; Semeraro F; Cancarini A; Rosei CA; Sarkar A; Ruggeri G; Caimi L; Ricotta D; Rizzoni D; Rosei EA
    J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of antihypertensive treatment on carotid vascular changes].
    Pompeo F; De Luca N; Marchegiano R; Gisonni P; Iovino G; D'Auria F; Del Mastro L; Simonelli P; Trimarco B
    Minerva Cardioangiol; 1994 Nov; 42(11):511-5. PubMed ID: 7700540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
    Tsioufis K; Tsioufis C; Dimitriadis K; Mantzouranis E; Mani I; Tousoulis D
    Curr Med Res Opin; 2016 Oct; 32(sup2):35-41. PubMed ID: 27779461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ; van Ouwerkerk BM; van der Meulen J; Zwinderman AH
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lercanidipine: a review of its use in hypertension.
    McClellan KJ; Jarvis B
    Drugs; 2000 Nov; 60(5):1123-40. PubMed ID: 11129125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.
    De Ciuceis C; Flati V; Rossini C; Rufo A; Porteri E; Di Gregorio J; Petroboni B; La Boria E; Donini C; Pasini E; Agabiti Rosei E; Rizzoni D
    Blood Press; 2014 Dec; 23(6):330-8. PubMed ID: 24786779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
    Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
    Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE ROLE PLEIOTROPIC EFFECTS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE IN PERIOPERATIVE THERAPY OF ARTERIAL HYPERTENSION.].
    Melnik MV; Afonicheva II; Beloborodova AV
    Anesteziol Reanimatol; 2016 Sep; 61(5):395-398. PubMed ID: 29489111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF; Gerocarni B; Rosticci M; Borghi C
    Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
    Matsui Y; Eguchi K; O'Rourke MF; Ishikawa J; Miyashita H; Shimada K; Kario K
    Hypertension; 2009 Oct; 54(4):716-23. PubMed ID: 19667251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of COER-verapamil on circadian pattern of forearm vascular resistance and blood pressure.
    Nguyen BN; Parker RB; Noujedehi M; Sullivan JM; Johnson JA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1480-7. PubMed ID: 11185670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
    Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
    BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.
    Matsui Y; O'Rourke MF; Hoshide S; Ishikawa J; Shimada K; Kario K
    Hypertension; 2012 Jun; 59(6):1132-8. PubMed ID: 22547439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of the treatment: combination of benazepril/lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension.
    Chen T; Chen GH; Yang TS; Zhong ZY; An WS; Zhang XX; Li JD
    Chin Med J (Engl); 2013 Jun; 126(12):2286-90. PubMed ID: 23786940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
    Omboni S; Zanchetti A
    J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
    Ghiadoni L; Bruno RM; Cartoni G; Stea F; Magagna A; Virdis A; Grassi D; Ferri C; Taddei S
    Vascul Pharmacol; 2017 May; 92():16-21. PubMed ID: 26070528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.